Revised SPC: Maxitrol products
SPC now recommends that, because of the possibility of reduced glucose tolerance/diabetes mellitus with topical ophthalmic corticosteroids, caution is recommended when administering maxitrol to patients with a personal or family history of diabetes.
Source:
electronic Medicines compendium